Stoke Therapeutics, Inc. business relationships
Companies named in Stoke Therapeutics, Inc.’s 10-K filed 2026-03-16, and public companies whose annual reports name Stoke Therapeutics, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 3.5 / 10
- AI naming
- <1 / 100 Top 55% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Named in Stoke Therapeutics, Inc.’s annual report 4
“For instance, pursuant to the Biogen Agreement, Biogen has certain rights to prepare, file, prosecute, and maintain certain patents and patent applications licensed to Biogen in the Biogen Territory.” SEC filing
“For example, we are a party to a license agreement with Biogen, pursuant to which we out-license key patents and patent applications related to zorevunersen and certain related products.” SEC filing
“We are collaborating with Biogen on the development and commercialization of zorevunersen outside of the U.S., Canada and Mexico.” SEC filing
“License and Collaboration Agreement with Acadia Pharmaceuticals Inc.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.